Initiator Pharma A/S (STO: INIT)

Initiator Pharma Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	382	485	317	356	133	188
Market Cap Growth	3.19%	52.80%	-10.94%	167.93%	-29.18%	153.41%
Enterprise Value	364	475	268	318	121	175
Last Close Price	6.80	9.24	6.06	8.14	4.51	7.47
Forward PE	-	16.58	7.36	-	-	-
PB Ratio	15.96	29.13	6.23	7.36	6.84	13.51
P/TBV Ratio	17.37	29.13	6.23	7.36	6.84	13.56
Debt / Equity Ratio	-	1.38	0.37	0.38	-	-
Quick Ratio	11.79	9.34	26.54	7.10	13.01	6.89
Current Ratio	11.79	9.34	27.70	9.91	13.06	7.45
Return on Equity (ROE)	-83.61%	-101.24%	-111.44%	-85.27%	-71.53%	-62.60%
Return on Assets (ROA)	-45.17%	-43.24%	-51.13%	-41.61%	-48.68%	-40.58%
Return on Capital (ROIC)	-49.02%	-46.16%	-54.99%	-46.00%	-54.13%	-44.09%
Earnings Yield	-3.90%	-7.04%	-18.15%	-8.18%	-8.83%	-6.19%
FCF Yield	-4.13%	-5.43%	-15.43%	-13.24%	-8.18%	-6.39%
Buyback Yield / Dilution	-4.53%	-7.60%	-51.69%	-28.17%	-12.92%	-20.72%
Total Shareholder Return	-4.53%	-7.60%	-51.69%	-28.17%	-12.92%	-20.72%

Source: S&P Capital IQ. Standard template. Financial Sources.